Systematic review of 57 studies (40,537 women with ovarian cancer): in majority White cohorts, an NBN pathogenic variant was associated with ovarian cancer (OR 1.68; estimated lifetime risk 3.32%). Data in non-White cohorts were insufficient.
Meta-analysisn = 40,537
Ganesan et al. Risk of ovarian cancer in women with a pathogenic or likely pathogenic variant in NBN: a systematic review and meta-analysis